-

VySpine Announces FDA Clearance for LumiVy Lumbar IBF System

TALLAHASSEE, Fla.--(BUSINESS WIRE)--VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its LumiVy Lumbar IBF System which is designed for use after lumbar discectomy in fusion procedures.

The LumiVy Lumbar IBF System features lumbar interbody fusion devices made from either PEEK Optima LT1 or PEEK Optima HA-Enhanced. PEEK Optima LT1 has been the standard for interbody devices for decades due to its radiolucency and a modulus of elasticity close to that of natural bone. PEEK Optima HA-Enhanced has embedded Hydroxyapatite fibers to create better bony apposition to the implant.

“The LumiVy Lumbar IBF System is our latest innovation in a series of comprehensive interbody systems being developed by VySpine,” said Tom McLeer, CEO of VySpine. “The LumiVy system addresses all lumbar approaches while offering the broadest range of differentiated materials for optimal bony integration. Using new materials and surgeon input, we are building exceptional quality, flexibility, and pricing into all our products.”

The LumiVy Lumbar IBF System is offered in numerous footprints and heights, and addresses a full range of lumbar interbody approaches including anterior, oblique anterior, lateral, oblique posterior, posterior, and transforaminal. Additionally, the LumiVy implants are available in a wide range of lordosis. The LumiVy Lumbar IBF System also features IBF-S implants, which have self-drilling screws to aid in anchoring the device directly to the bone.

About VySpine

VySpine was created through active internal development and the licensing of various proven technologies using innovative materials and designs. This comprehensive line of core spine products and newly developed specialty products allow us to meet the needs of both health care providers and surgeons. The company strives to outpace the competition by collaborating with key spine innovators while providing a flexible, cost-effective approach to spine care. Learn more at vyspine.com

“VySpine” and “LumiVy” are registered trademarks of VySpine.

“PEEK Optima” is a registered trademark of Invibio Biomaterial Solutions.

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com.

VySpine


Release Summary
VySpine has received FDA clearance for its LumiVy Lumbar IBF System, designed for use after lumbar discectomy in fusion procedures.
Release Versions

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com.

More News From VySpine

Vy Spine Announces FDA Clearance of 3D Printed LumiVy OsteoVy PEKK Lumbar IBF

BOUNTIFUL, Utah--(BUSINESS WIRE)--Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its LumiVy OsteoVy PEKK Lumbar IBF. The device is indicated for intervertebral body fusion for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis. The LumiVy OsteoVy PEKK...

Vy Spine Announces FDA Clearance for its ClariVy OsteoVy PEKK Cervical IBF

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its ClariVy OsteoVy PEKK Cervical IBF, indicated for intervertebral body fusion for use at one level in the cervical spine, from C3 to T1, for the treatment of degenerative disc disease (DDD). The novel ClariVy OsteoVy PEKK Cervical IBF device combines the osseointegration properties of the...

VySpine Announces FDA Clearances for VySpan, VyLam and VySpine Innovations

TALLAHASSEE, Fla.--(BUSINESS WIRE)--VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received a trio of U.S. Food and Drug Administration (FDA) clearances for its products, providing increased diversity to the company’s portfolio. Among the approvals announced is FDA clearance for additional connectors for the VySpan PCT system to add to its versatility. These new, robust connectors can be easily attached to the VyLink Screw System. VySp...
Back to Newsroom